Company Profile
Kazia Therapeutics Limited Stock Price, News & Analysis
- Ticker:
- KZIA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Kazia Therapeutics Limited is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
14.69 USD (+4.93%)
Close
Last updated: June 23, 2026 at 00:00
167.86M USD
Market cap
Why the stock is moving
KZIA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kazia Therapeutics Limited is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Kazia Therapeutics Limited follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Kazia Therapeutics Limited sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kazia Therapeutics Limited (KZIA)?
Kazia Therapeutics Limited (KZIA) most recently closed at 14.69 USD, a +4.93% move versus the previous session.
What is the market cap of Kazia Therapeutics Limited (KZIA)?
Kazia Therapeutics Limited currently has a market capitalization of 167.86M USD on BioPharmSignal.
What does Kazia Therapeutics Limited do?
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is KZIA stock listed?
Kazia Therapeutics Limited (KZIA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Kazia Therapeutics Limited is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Kazia?
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Kazia Therapeutics Limited targeting with Kazia?
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Limited?
Kazia Therapeutics Limited is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.